Journals / Dahili ve Cerrahi Bilimler Yoğun Bakım Dergisi / 2016 / Cilt: 7 - Sayı: 1

Pediatric Olanzapine Intoxications and Plasma Exchange Application in One Case: Four Case Reports

Pediatrik Olanzapin Zehirlenmeleri ve Bir Olguda Plazma Değişimi Uygulaması: Dört Olgu Sunumu

Pages
34–38
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result, although there were no correlations between olanzapine blood levels and clinical signs, therapeutic plasma exchange should be considered as a treatment for severe cases because of the clinical improvement observed during the procedure.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Olanzapine intoxications are frequently known as benign.
📊
Key Findings & Data:Because of increased olanzapine blood levels 24 h after therapeutic plasma exchange, which decreased immediately after the procedure, we decided to continue with the therapeutic plasma exchange treatment.
💡
Conclusion & Impact:As a result, although there were no correlations between olanzapine blood levels and clinical signs, therapeutic plasma exchange should be considered as a treatment for severe cases because of the clinical improvement observed during the procedure.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Olanzapine intoxications are frequently known as benign. However, there are case reports on death due to olanzapine intoxications in the literature. We present four olanzapine intoxication cases that were followed at our pediatric intensive care unit. We compared the olanzapine blood levels and severity of clinical signs. We observed that there were no correlations between blood olanzapine levels and clinical signs in mild cases. Therapeutic plasma exchange was performed for the severe intoxication case because of olanzapine high protein binding. Because of increased olanzapine blood levels 24 h after therapeutic plasma exchange, which decreased immediately after the procedure, we decided to continue with the therapeutic plasma exchange treatment. We also observed that there were no correlations between olanzapine blood levels and clinical signs in the severe case. As a result, although there were no correlations between olanzapine blood levels and clinical signs, therapeutic plasma exchange should be considered as a treatment for severe cases because of the clinical improvement observed during the procedure.

Özet

Olanzapin zehirlenmeleri sıklıkla selim seyretmekle birlikte literatürde zehirlenme sonrasında ölüm olguları bildirilmektedir. Kliniğimizde takip edilmiş olan biri ağır seyirli dört olgu takipleri sırasında kaydedilen olanzapin kan düzeyleriyle birlikte klinik tablonun ağırlık derecesi karşılaştırılarak sunulmuştur. Hafif seyirli olgularda kan düzeyi ve klinik bulgular arasında ilişki gözlenmedi. Ağır seyirli olguda olanzapinin yüksek protein bağlanma oranı nedeniyle tedavi edici plazma değişimi uygulandı. Tedavi edici plazma değişimi sonrası kan düzeylerinin ciddi oranda gerilediği ancak 24 saat içinde tekrar yükseldiğinden tekrar uygulanması gerektiği düşünüldü. Ağır seyirli olguda da kan düzeyiyle klinik bulgular arasında ilişki gözlenmedi. Sonuç olarak olgularda olanzapin kan düzeyi ve klinik bulgular arasında anlamlı ilişki belirlenmemesine rağmen, ağır seyreden olgumuzda tedavi edici plazma değişimiyle klinik seyrin düzeldiği gözlemlendiğinden, ağır seyreden olgularda tedavi edici plazma değişimi tedavi seçeneği olarak düşünülebilir.

🔖

Cite This Article

YEŞİLBAŞ, O., ŞEVKETOĞLU, E., KIHTIR, H. S., YILDIRIM, H. M., KIHTIR, Z. (2022). Pediatric Olanzapine Intoxications and Plasma Exchange Application in One Case: Four Case Reports. Dahili ve Cerrahi Bilimler Yoğun Bakım Dergisi, Cilt: 7 - Sayı: 1, 34–38. https://ajindex.com/articles/486571

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Laughren T. P. Full prescribing information of Zyprexa. U.S. Food and drug administration Available from: http://www.fda.gov/downloads/ AdvisoryComm%20ittees/CommitteesMeeting Materials/ PediatricAdvisoryCommittee/UCM191898.pdf 2. Sumer V, Guler E, Karanfil R, et al. Evaluation of the poisoning cases who applied to the pediatrics emergency unit. Turk Arch Ped 2011;46:234-40. 3. Güzel IŞ, Kibar AE, Vidinlisan S. Çocuk acil servisine başvuran zehirlenme vakalarının demografik özelliklerinin incelenmesi. Genel Tıp Derg 2011;21:101-7. 4. Meli M, Rauber-Lüthy C, Hoffmann-Walbeck P, et al. Atypical antipsychotic poisoning in young children: a multicentre analysis of poisons centres data. Eur J Pediatr 2014;173:743-50. [CrossRef] 5. Isbister GK, Balit CR, Kilham HA. Antipsychotic poisoning in young children a systematic review. Drug Saf 2005;28:1029-44. [CrossRef] 6. Chue P, Singer P. A review of olanzapine-associated toxicity and fatality in overdose. J Psychiatry Neurosci 2003;28:253-61. 7. Callaghan JT, Bergstrom RF, Ptak LR, et al. Olanzapine. Pharmacokinetic and pharmacodynamic profile. Clin Pharmacokinet 1999;37:177-93. [CrossRef] 8. Stübner S, Grohmann R, Engel R, et al. Blood dyscrasias induced by psychotropic drugs. Pharmacopsychiatry 2004;37:70-8. [CrossRef] 9. Kodesh A, Finkel B, Lerner AG, et al. Dose-dependent olanzapine-associated leukopenia: three case reports. Int Clin Psychopharmacol 2001;16:117-9. [CrossRef] 10. Schwartz S, Winters JL, Padmanabhan A, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special ıssue. J Clin Apher 2013;28:145-284. [CrossRef]